ACHN: Summary for Achillion Pharmaceuticals, Inc. - Yahoo Finance

UK Markets closed

Achillion Pharmaceuticals, Inc. (ACHN)


NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.07-0.08 (-1.93%)
As of 11:54AM EST. Market open.
People also watch
FOLDACADCLDXARIAARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close4.15
Open4.13
Bid4.07 x 300
Ask4.08 x 2800
Day's range4.07 - 4.14
52-week range3.78 - 10.06
Volume396,672
Avg. volume2,172,141
Market cap556.29M
Beta2.64
PE ratio (TTM)-10.88
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Achillion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACHN) : January 11, 2017
    Capital Cube8 days ago

    Achillion Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ACHN) : January 11, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Achillion Pharmaceuticals, Inc. a score of 25. Our analysis is based on comparing Achillion Pharmaceuticals, Inc. with the following peers – Vertex Pharmaceuticals Incorporated, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Enanta Pharmaceuticals, Inc., GlaxoSmithKline plc Sponsored ADR, Johnson & Johnson, NanoViricides, Inc., AbbVie, Inc., Merck & Co., ... Read more (Read more...)

  • Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US : January 10, 2017
    Capital Cube9 days ago

    Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US : January 10, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Achillion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Achillion Receives $15M from J&J for HCV Study Enrolment
    Zacks21 days ago

    Achillion Receives $15M from J&J for HCV Study Enrolment

    Achillion Pharmaceuticals, Inc. (ACHN) announced that it has received a milestone payment of $15 million from Johnson & Johnson's (JNJ) pharma wing, Janssen for the initiation of patient enrollment in the OMEGA-1 phase IIb global study of JNJ-4178.